{"nct_id":"NCT06298552","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2024-04-16","start_date_type":"ACTUAL","primary_completion_date":"2025-07-25","primary_completion_date_type":"ESTIMATED","completion_date":"2027-07-23","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ARGX"]}